Oncological Differences Between Transanal and Laparoscopic Total Mesorectal Excision for Rectal Cancer.

Launched by YANHONG DENG · Jan 20, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at two different surgical methods for treating rectal cancer: laparoscopic surgery, which uses small incisions and a camera, and transanal endoscopy, which involves accessing the rectum directly. The main goal is to see if there are any differences in how effective these two methods are for removing rectal tumors and how they affect patients' outcomes after surgery.

If you or someone you know has a primary rectal tumor that is not too large (less than 6 cm) and hasn't spread to other parts of the body, you may be eligible to participate in this study. Participants will undergo one of the two surgical procedures and will be monitored for their recovery and overall health outcomes. It's important to note that individuals with a history of other types of cancer, certain severe health conditions, or those who are pregnant cannot participate. This trial is currently recruiting patients, and it aims to help improve treatment options for rectal cancer in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Primary rectal carcinoma
• • Single lesion
• • No metastasis
• Exclusion Criteria:
• • History of malignant tumors
• • Acute bowel obstruction, bleeding or perforation
• • Tumor over 6cm in diameter or in severe adhesion with surrounded tissues
• • Severe other contradictions of surgery
• • Pregnant women will be excluded